Cited 5 times in
Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.